Aviso: para depositar documentos, por favor, inicia sesión e identifícate con tu cuenta de correo institucional de la UCM con el botón MI CUENTA UCM. No emplees la opción AUTENTICACIÓN CON CONTRASEÑA
 

Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3

dc.contributor.authorRodríguez Cueto, Carmen Aurora
dc.contributor.authorHernández-Gálvez, Mariluz
dc.contributor.authorHillard, Cecilia
dc.contributor.authorMaciel, Patricia
dc.contributor.authorGarcía-García, Luis
dc.contributor.authorValdeolivas, Sara
dc.contributor.authorPozo García, Miguel Ángel
dc.contributor.authorRamos Atance, José Antonio
dc.contributor.authorGómez Ruiz, María Sagrario
dc.contributor.authorFernández Ruiz, José Javier
dc.contributor.authorGarcía García, Luis
dc.date.accessioned2024-01-16T14:06:12Z
dc.date.available2024-01-16T14:06:12Z
dc.date.issued2016
dc.description.abstractSpinocerebellar ataxia type-3 (SCA-3) is a rare disease but it is the most frequent type within the autosomal dominant inherited ataxias. The disease lacks an effective treatment to alleviate major symptoms and to modify disease progression. Our recent findings that endocannabinoid receptors and enzymes are significantly altered in the post-mortem cerebellum of patients affected by autosomal-dominant hereditary ataxias suggest that targeting the endocannabinoid signaling system may be a promising therapeutic option. Our goal was to investigate the status of the endocannabinoid signaling system in a transgenic mouse model of SCA-3, in the two CNS structures most affected in this disease - cerebellum and brainstem. These animals exhibited progressive motor incoordination, imbalance, abnormal gait, muscle weakness, and dystonia, in parallel to reduced in vivo brain glucose metabolism, deterioration of specific neuron subsets located in the dentate nucleus and pontine nuclei, small changes in microglial morphology, and reduction in glial glutamate transporters. Concerning the endocannabinoid signaling, our data indicated no changes in CB2 receptors. By contrast, CB1 receptors increased in the Purkinje cell layer, in particular in terminals of basket cells, but they were reduced in the dentate nucleus. We also measured the levels of endocannabinoid lipids and found reductions in anandamide and oleoylethanolamide in the brainstem. These changes correlated with an increase in the FAAH enzyme in the brainstem, which also occurred in some cerebellar areas, whereas other endocannabinoid-related enzymes were not altered. Collectively, our results in SCA-3 mutant mice confirm a possible dysregulation in the endocannabinoid system in the most important brain structures affected in this type of ataxia, suggesting that a pharmacological manipulation addressed to correct these changes could be a promising option in SCA-3.
dc.description.departmentDepto. de Bioquímica y Biología Molecular
dc.description.facultyFac. de Medicina
dc.description.refereedTRUE
dc.description.sponsorshipMinisterio de Ciencia e Innovación (España)
dc.description.sponsorshipCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
dc.description.sponsorshipFundación Eugenio Rodríguez Pascual
dc.description.statuspub
dc.identifier.citationRodríguez-Cueto C, Hernández-Gálvez M, Hillard CJ, Maciel P, García-García L, Valdeolivas S, Pozo MA, Ramos JA, Gómez-Ruiz M, Fernández-Ruiz J. Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3. Neuroscience. 2016 Dec 17;339:191-209. doi: 10.1016/j.neuroscience.2016.09.046. Epub 2016 Oct 4. PMID: 27717809.
dc.identifier.doi10.1016/j.neuroscience.2016.09.046
dc.identifier.issn0306-4522
dc.identifier.officialurlhttps://doi.org/10.1016/j.neuroscience.2016.09.046
dc.identifier.pmid27717809
dc.identifier.urihttps://hdl.handle.net/20.500.14352/93390
dc.issue.number39
dc.journal.titleNeuroscience
dc.language.isoeng
dc.page.final209
dc.page.initial191
dc.publisherElsevier
dc.relation.projectIDinfo:eu-repo/grantAgreement/MICINN//SAF2009-11847/ES/Estudio De Los Mecanismos Implicados En La Neuroproteccion Con Cannabinoides Antioxidantes Y Agonistas Cb2 En Varias Enfermedades Neurodegenerativas/
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO//SAF2015-68580-C2-1-R/ES/DIANAS EN EL SISTEMA ENDOCANNABINOIDE PARA EL DESARROLLO DE TERAPIAS FRENTE A LA NEURODEGENERACION: ENFASIS EN LA ELA Y OTRAS ENFERMEDADES NEURODEGENERATIVAS/
dc.relation.projectIDinfo:eu-repo/grantAgreement/MSC//CB06%2F05%2F0089/ES/Enfermedades genéticas 89/
dc.rights.accessRightsrestricted access
dc.subject.cdu577.1
dc.subject.keywordMachado-Joseph disease
dc.subject.keywordAutosomal-dominant inherited ataxias
dc.subject.keywordCannabinoids
dc.subject.keywordEndocannabinoid signaling system
dc.subject.keywordMotor incoordination
dc.subject.keywordSpinocerebellar ataxia-3
dc.subject.ucmCiencias Biomédicas
dc.subject.ucmCiencias
dc.subject.unesco24 Ciencias de la Vida
dc.titleDysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number17
dspace.entity.typePublication
relation.isAuthorOfPublicationa19d29d6-cf5c-4a37-881e-606e18e3efca
relation.isAuthorOfPublication2c1f3cf9-4ed9-46b4-8ca7-0170836b5350
relation.isAuthorOfPublication7163c673-ac6c-4c73-b682-286b5a23877d
relation.isAuthorOfPublication104fecd1-dbc7-4a1a-9c53-c0f4ab4609f7
relation.isAuthorOfPublicationa397c938-999a-4def-a947-7f49b94dceb0
relation.isAuthorOfPublication42c35a76-2b7a-4d5c-8662-f346eb275064
relation.isAuthorOfPublication.latestForDiscoverya19d29d6-cf5c-4a37-881e-606e18e3efca

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Endocannabinoid_signaling_system.pdf
Size:
11.75 MB
Format:
Adobe Portable Document Format

Collections